(CNN)– Drug maker Novo Nordisk has filed a lawsuit against telehealth provider Hims and Hers over alleged copycat versions of its weight-loss and obesity medications. The lawsuit, filed Tuesday, Feb. 10, 2026, accuses Hims and Hers of making compounded knock off versions of the popular dr ugs Ozempic and Wegovy. Novo Nordisk estimates one and a half million people in the U.S. are using compound versions of its drugs. When the drugs were in short supply the FDA allowed compounding pharmacies to make similar medications to fill gaps for patients. But Ozempic and Wegovy were removed from the shortage list last year. Categories: News Tags: GLP-1 weight loss drugs, Hims and Hers, Novo Nordisk ...read more read less